Volume 15, Number 3—March 2009
Research
Integron-mediated Multidrug Resistance in a Global Collection of Nontyphoidal Salmonella enterica Isolates
Mary G. Krauland, Jane W. Marsh, David L. Paterson, and Lee H. Harrison
Table 3
Source and ACSSuT resistance in a global collection of Salmonella enterica isolates*
| Source | Total no. isolates | No. (%) ACSSuT-resistant isolates |
|---|---|---|
| Argentina | 148 | 0 |
| Australia | 146 | 0 |
| Belgium | 66 | 0 |
| Canada | 144 | 0 |
| Denmark | 153 | 8 (5.2) |
| Germany | 150 | 1 (0.7) |
| Italy | 156 | 3 (1.9) |
| Philippines | 67 | 6 (8.9) |
| Spain | 151 | 8 (5.3) |
| South Africa | 160 | 30 (18.8) |
| Taiwan | 150 | 29 (19.3) |
| United States/ACHD | 179 | 8 (4.5) |
| United States/CDC | 150 | 1 (0.7) |
| Uganda |
100 |
10 (10.0) |
| Total | 1,920 | 104 (5.4) |
*ACSSuT, ampicillin, chloramphenicol, streptomycin, sulfamethoxazole, and tetracycline; ACHD, Allegheny County Health Department; CDC, Centers for Disease Control and Prevention.
Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.